Journal of Clinical and Experimental Ophthalmology
Open Access
ISSN: 2155-9570
ISSN: 2155-9570
Holostem Srl, Centre for Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy
Research Article
Optimizing Vision Restoration: Experience with Holoclar Treatment, the Selection of a Qualified Treatment Center, Accessibility to Patients and Outcomes
Author(s): Cecilia Marinova*, Eva Vlkova, Monika Horackova, Magdalena Netukova, Pavlina Skalicka, Graziella Pellegrini, Veronika Sladkova, Martina Losova and Sandra Skvarlova
Moving towards personalized medicine brings the novel challenge of connecting highly specific treatments with the
patients who can benefit from them. One such treatment is the cell therapy Holoclar®, approved for use in adult
patients with moderate to severe Limbal Stem Cell Deficiency (LSCD) caused by trauma (burns, chemical burns to
the eyes). It takes significant effort and time to establish a qualified Holoclar® Treatment Center (HTC). The efficacy
of an HTC is assessed based upon the number of treated patients. We evaluated new approaches to improving
patient access to the HTC and thus commercial sustainability for Holoclar®.
We mapped new patient pathways and the role of cooperation, networking, coordination among centers and
clinical outcomes and focused on the accessibility of Holoclar® acros.. View More»
DOI:
10.35248/2155-9570.24.15.971